Keytruda/Welireg and Welireg/Lenvima combinations show improved survival and disease control in kidney cancer, according to new data from ASCO GU. The third and final day of the 2026 American Society ...
Day two of ASCO GU highlighted innovative therapies and the need for better quality-of-life reporting in genitourinary cancer trials. The second day of the 2026 American Society of Clinical Oncology ...
(RTTNews) - Natera Inc. (NTRA) presented new findings at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) on the use of its Signatera molecular residual disease (MRD ...
Two surgical trainees share their perspectives on the importance of collaboration, innovation, and nightlife at the ASCO Genitourinary Cancers Symposium 2026. Each year, the ASCO Genitourinary Cancers ...
Flatiron Health today announced its presence at the American Society of Genitourinary Cancers Symposium happening from February 26-28, 2026, in San Francisco, California. Flatiron's real-world data ...
Availability of clinical trials investigating prostate cancer (PC) in the United States (US). Rucaparib vs docetaxel (DTX) or second-generation androgen receptor pathway inhibitor (ARPI) therapy for ...
Renal and Urology News, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve ...
Impact of treatment approaches on survival in bulky node-positive penile squamous cell carcinoma: A National Cancer Database analysis. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary ...
Lower levels of microplastics also detected in most healthy prostate tissue. HealthDay News — Microplastics have been found in most prostate tumors, according to a small study presented at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results